FR2262513B1 - - Google Patents

Info

Publication number
FR2262513B1
FR2262513B1 FR7407002A FR7407002A FR2262513B1 FR 2262513 B1 FR2262513 B1 FR 2262513B1 FR 7407002 A FR7407002 A FR 7407002A FR 7407002 A FR7407002 A FR 7407002A FR 2262513 B1 FR2262513 B1 FR 2262513B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7407002A
Other languages
French (fr)
Other versions
FR2262513A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Delalande SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delalande SA filed Critical Delalande SA
Priority to FR7407002A priority Critical patent/FR2262513A1/fr
Publication of FR2262513A1 publication Critical patent/FR2262513A1/fr
Application granted granted Critical
Publication of FR2262513B1 publication Critical patent/FR2262513B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7407002A 1974-03-01 1974-03-01 3,4,5-Triphenyl-delta-1,2,4-oxadiazolines - with bronchodilator, anti-cholinergic, hypertensive, analgesic and sedative activity Granted FR2262513A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7407002A FR2262513A1 (en) 1974-03-01 1974-03-01 3,4,5-Triphenyl-delta-1,2,4-oxadiazolines - with bronchodilator, anti-cholinergic, hypertensive, analgesic and sedative activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7407002A FR2262513A1 (en) 1974-03-01 1974-03-01 3,4,5-Triphenyl-delta-1,2,4-oxadiazolines - with bronchodilator, anti-cholinergic, hypertensive, analgesic and sedative activity

Publications (2)

Publication Number Publication Date
FR2262513A1 FR2262513A1 (en) 1975-09-26
FR2262513B1 true FR2262513B1 (enExample) 1978-07-21

Family

ID=9135659

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7407002A Granted FR2262513A1 (en) 1974-03-01 1974-03-01 3,4,5-Triphenyl-delta-1,2,4-oxadiazolines - with bronchodilator, anti-cholinergic, hypertensive, analgesic and sedative activity

Country Status (1)

Country Link
FR (1) FR2262513A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7666870B2 (en) 2004-08-26 2010-02-23 Maybridge Limited Phthalazinone derivatives
US7750006B2 (en) 2000-10-30 2010-07-06 Kudos Pharmaceuticals Limited Phthalazinone derivatives
US8183369B2 (en) 2007-10-17 2012-05-22 Kudos Pharmaceuticals Limited 4- [3- (4-cyclopropanecarbonyl-piperazine-I-carbonyl) -4 -fluoro-benzyl] -2H-phthalaz in-1-one

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003229953A1 (en) * 2002-04-30 2003-11-17 Kudos Pharmaceuticals Limited Phthalazinone derivatives
US7449464B2 (en) 2003-03-12 2008-11-11 Kudos Pharmaceuticals Limited Phthalazinone derivatives
GB0305681D0 (en) 2003-03-12 2003-04-16 Kudos Pharm Ltd Phthalazinone derivatives
GB0521373D0 (en) 2005-10-20 2005-11-30 Kudos Pharm Ltd Pthalazinone derivatives
JP2010539149A (ja) 2007-09-14 2010-12-16 アストラゼネカ アクチボラグ フタラジノン誘導体
AR070221A1 (es) 2008-01-23 2010-03-25 Astrazeneca Ab Derivados de ftalazinona inhibidores de polimerasas, composiciones farmaceuticas que los contienen y usos de los mismos para prevenir y/o tratar tumores cancerigenos,lesiones isquemicas y otras enfermedades asociadas.
ES2598178T5 (es) 2008-10-07 2023-12-26 Kudos Pharm Ltd Formulación farmacéutica 514

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7750006B2 (en) 2000-10-30 2010-07-06 Kudos Pharmaceuticals Limited Phthalazinone derivatives
US7666870B2 (en) 2004-08-26 2010-02-23 Maybridge Limited Phthalazinone derivatives
US8183369B2 (en) 2007-10-17 2012-05-22 Kudos Pharmaceuticals Limited 4- [3- (4-cyclopropanecarbonyl-piperazine-I-carbonyl) -4 -fluoro-benzyl] -2H-phthalaz in-1-one

Also Published As

Publication number Publication date
FR2262513A1 (en) 1975-09-26

Similar Documents

Publication Publication Date Title
AU495028B2 (enExample)
AU495920B2 (enExample)
AR198786Q (enExample)
AU7465674A (enExample)
AU7478474A (enExample)
BE836983A (enExample)
AU481765A (enExample)
AU479768A (enExample)
AU480187A (enExample)
AU480348A (enExample)
AU480559A (enExample)
AU480622A (enExample)
AU480660A (enExample)
AU480879A (enExample)
AU480922A (enExample)
AU481044A (enExample)
AU481265A (enExample)
AU481500A (enExample)
BG19670A1 (enExample)
AU481545A (enExample)
BG19662A1 (enExample)
AU482294A (enExample)
AU482307A (enExample)
BE830202A (enExample)
CH593082A5 (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse